Skip to main content

Market Overview

7 Healthcare Stocks Moving In Friday's Pre-Market Session

Share:

Gainers

  • Sierra Oncology, Inc. (NASDAQ: SRRA) shares increased by 43.3% to $0.55 during Friday's pre-market session. The market cap stands at $23.1 million. The most recent rating by Oppenheimer, on December 06, is at Outperform, with a price target of $1.20.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) stock moved upwards by 40.6% to $2.53. The market value of their outstanding shares is at $20.6 million.
  • Puma Biotechnology, Inc. (NASDAQ: PBYI) stock increased by 5.9% to $7.88. The market cap seems to be at $264.8 million. The most recent rating by Goldman Sachs, on October 08, is at Sell, with a price target of $8.00.
  • Celyad, Inc. (NASDAQ: CYAD) stock rose 4.3% to $12.58. The market cap seems to be at $135.9 million.
  • Sage Therapeutics, Inc. (NASDAQ: SAGE) stock rose 2.4% to $61.64. The market value of their outstanding shares is at $7.0 billion. According to the most recent rating by SVB Leerink, on December 06, the current rating is at Market Perform.

 

Losers

  • Sienna Biopharmaceuticals, Inc. (NASDAQ: SNNA) stock plummeted 13.1% to $0.20 during Friday's pre-market session. The market cap stands at $5.4 million.
  • Bionano Genomics, Inc. (NASDAQ: BNGO) stock declined 5.5% to $1.03. The market cap stands at $20.9 million.
 

Related Articles (CYAD + BNGO)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com